1. V. Brochard, B. Combadiere, A. Prigent, Y. Laouar, A. Perrin, V. Beray-Berthat, O. Bonduelle, D. Alvarez-Fischer, J. Callebert, J. M. Launay, C. Duyckaerts, R. A. Flavell, E. C. Hirsch, and S. Hunot. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest, 119(1):182-92, 2009. Note: Howard Hughes Medical Institute/United StatesJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW]



2. E. C. Hirsch and S. Hunot. Neuroinflammation in Parkinson's disease: a target for neuroprotection?. Lancet Neurol, 8(4):382-97, 2009. Note: Journal ArticleReviewEngland. [WWW] Keyword(s): Animals, Anti-Inflammatory Agents/therapeutic use, Cell Death/physiology, Dopamine/metabolism, Humans, Immunization, Immunologic Factors/therapeutic use, Inflammation/*pathology/*physiopathology, Nerve Degeneration/physiopathology/therapy, *Neuroimmunomodulation, Neurons/physiology, Neuroprotective Agents/therapeutic use, Parkinson Disease/*pathology/*physiopathology/therapy.



3. D. Alvarez-Fischer, S. Guerreiro, S. Hunot, F. Saurini, M. Marien, P. Sokoloff, E. C. Hirsch, A. Hartmann, and P. P. Michel. Modelling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecid. J Neurochem, 107(3):701-11, 2008. Note: Journal ArticleResearch Support, Non-U.S. Gov'tEngland. [WWW] Keyword(s): 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine/*administration & dosage, Adjuvants, Pharmaceutic/administration & dosage, Animals, Brain/drug effects/pathology, Chromatography, High Pressure Liquid, *Disease Models, Animal, Dopamine/analysis/metabolism, Immunohistochemistry, *Infusion Pumps, Male, Mice, Mice, Inbred C57BL, Nerve Degeneration/chemically induced, Neurotoxins/*administration & dosage, Parkinsonian Disorders/*chemically induced, Probenecid/*administration & dosage.



4. J. E. Ferrario, A. E. Rojas-Mayorquin, M. Saldana-Ortega, C. Salum, M. Z. Gomes, S. Hunot, and R. Raisman-Vozari. Pleiotrophin receptor RPTP-zeta/beta expression is up-regulated by L-DOPA in striatal medium spiny neurons of parkinsonian rats. J Neurochem, 107(2):443-52, 2008. Note: Journal ArticleResearch Support, Non-U.S. Gov'tEngland. [WWW] Keyword(s): Analysis of Variance, Animals, Antiparkinson Agents/*pharmacology/therapeutic use, Behavior, Animal/drug effects, Corpus Striatum/*pathology, Disease Models, Animal, Drug Interactions, Levodopa/*pharmacology/therapeutic use, Male, Neurons/classification/*drug effects/metabolism, Oxidopamine, Parkinsonian Disorders/chemically induced/*drug therapy/pathology, RNA, Messenger/metabolism, Rats, Rats, Wistar, Receptor-Like Protein Tyrosine Phosphatases, Class 5/genetics/*metabolism, Up-Regulation/*drug effects.



5. J. Salazar, N. Mena, S. Hunot, A. Prigent, D. Alvarez-Fischer, M. Arredondo, C. Duyckaerts, V. Sazdovitch, L. Zhao, L. M. Garrick, M. T. Nunez, M. D. Garrick, R. Raisman-Vozari, and E. C. Hirsch. Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease. Proc Natl Acad Sci U S A, 105(47):18578-83, 2008. Note: Journal ArticleUnited States. [WWW]



6. G. U. Hoglinger, J. J. Breunig, C. Depboylu, C. Rouaux, P. P. Michel, D. Alvarez-Fischer, A. L. Boutillier, J. Degregori, W. H. Oertel, P. Rakic, E. C. Hirsch, and S. Hunot. The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease. Proc Natl Acad Sci U S A, 104(9):3585-90, 2007. Note: R24 mh 68855/mh/nimhComparative StudyJournal ArticleResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine/pharmacology, 1-Methyl-4-phenylpyridinium/pharmacology, Analysis of Variance, Animals, Apoptosis/*physiology, Chromatography, High Pressure Liquid, E2F1 Transcription Factor/genetics/*metabolism, Gene Expression Regulation/drug effects, Humans, Immunohistochemistry, In Situ Hybridization, Interneurons/drug effects/*metabolism, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Oligonucleotides, Antisense/genetics, Parkinson Disease/*physiopathology, Signal Transduction/drug effects, Substantia Nigra/*metabolism.



7. E. C. Hirsch, S. Hunot, and A. Hartmann. Neuroinflammatory processes in Parkinson's disease. Parkinsonism Relat Disord, 11 Suppl 1:S9-S15, 2005. Note: Journal ArticleReviewEngland. [WWW] Keyword(s): Encephalitis/*immunology/pathology, Humans, Neuroimmunomodulation/*immunology, Parkinson Disease/*immunology/pathology.



8. S. Hunot, M. Vila, P. Teismann, R. J. Davis, E. C. Hirsch, S. Przedborski, P. Rakic, and R. A. Flavell. JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease. Proc Natl Acad Sci U S A, 101(2):665-70, 2004. Note: Journal ArticleResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.Research Support, U.S. Gov't, P.H.S.United States. [WWW] Keyword(s): Animals, Base Sequence, Cyclooxygenase 2, DNA Primers, Disease Models, Animal, Immunohistochemistry, Isoenzymes/*biosynthesis, *JNK Mitogen-Activated Protein Kinases, MAP Kinase Kinase 4, Male, Mice, Mice, Inbred C57BL, Mitogen-Activated Protein Kinase Kinases/*metabolism, Parkinson Disease/*enzymology/pathology, Prostaglandin-Endoperoxide Synthases/*biosynthesis, Reverse Transcriptase Polymerase Chain Reaction.



9. A. Hartmann, S. Hunot, and E. C. Hirsch. Inflammation and dopaminergic neuronal loss in Parkinson's disease: a complex matter. Exp Neurol, 184(2):561-4, 2003. Note: CommentJournal ArticleReviewUnited States. [WWW] Keyword(s): Animals, Brain/metabolism/*pathology, Dopamine/metabolism, Humans, Inflammation/*pathology, Microglia/metabolism, Nerve Degeneration/*pathology, Neurons/metabolism/*pathology, Parkinson Disease/*pathology.



10. E. C. Hirsch, T. Breidert, E. Rousselet, S. Hunot, A. Hartmann, and P. P. Michel. The role of glial reaction and inflammation in Parkinson's disease. Ann N Y Acad Sci, 991:214-28, 2003. Note: Journal ArticleReviewUnited States. [WWW] Keyword(s): Animals, Anti-Inflammatory Agents/therapeutic use, Cytokines/metabolism, Dopamine/metabolism, Humans, Inflammation/etiology, Nerve Degeneration/physiopathology, *Neuroglia, Neurons/metabolism, Parkinson Disease/metabolism/pathology/*physiopathology.



11. S. Hunot and E. C. Hirsch. Neuroinflammatory processes in Parkinson's disease. Ann Neurol, 53 Suppl 3:S49-58;, 2003. Note: Journal ArticleResearch Support, Non-U.S. Gov'tReviewUnited States. [WWW] Keyword(s): Antigens, CD/immunology, Cell Death, Corpus Striatum/enzymology/immunology/pathology, Cyclooxygenase 2, Cytokines/immunology, Dopamine/immunology/metabolism, Humans, Interleukins/immunology, Isoenzymes/*metabolism, Major Histocompatibility Complex/immunology, Membrane Proteins, Mesencephalon/*pathology, Nerve Degeneration/pathology, Neuroglia/immunology/metabolism, Nitric Oxide Synthase/*metabolism, Parkinson Disease/*enzymology/immunology/*pathology, Prostaglandin-Endoperoxide Synthases/*metabolism.



12. P. Teismann, K. Tieu, D. K. Choi, D. C. Wu, A. Naini, S. Hunot, M. Vila, V. Jackson-Lewis, and S. Przedborski. Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration. Proc Natl Acad Sci U S A, 100(9):5473-8, 2003. Note: Ns11766-27a1/ns/nindsNs37345/ns/nindsNs38370/ns/nindsNs38586/ns/nindsNs42269/ns/nindsJournal ArticleResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.Research Support, U.S. Gov't, P.H.S.United States. [WWW] Keyword(s): 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine/pharmacology, Animals, Catalysis, Cyclooxygenase 2, Cyclooxygenase 2 Inhibitors, Cyclooxygenase Inhibitors/pharmacology, Enzyme Activation, Humans, Immunohistochemistry, Isoenzymes/*metabolism, JNK Mitogen-Activated Protein Kinases, Membrane Proteins, Mice, Mice, Inbred C57BL, Microglia/drug effects, Mitogen-Activated Protein Kinases/metabolism, Parkinson Disease/enzymology/*pathology, Prostaglandin-Endoperoxide Synthases/*metabolism, Reverse Transcriptase Polymerase Chain Reaction.

This material is presented to ensure timely dissemination of scholarly and technical work. Copyright and all rights therein are retained by authors or by other copyright holders. All person copying this information are expected to adhere to the terms and constraints invoked by each author's copyright. In most cases, these works may not be reposted without the explicit permission of the copyright holder.

Les documents contenus dans ces répertoires sont rendus disponibles par les auteurs qui y ont contribué en vue d'assurer la diffusion à temps de travaux savants et techniques sur une base non-commerciale. Les droits de copie et autres droits sont gardés par les auteurs et par les détenteurs du copyright, en dépit du fait qu'ils présentent ici leurs travaux sous forme électronique. Les personnes copiant ces informations doivent adhérer aux termes et contraintes couverts par le copyright de chaque auteur. Ces travaux ne peuvent pas être rendus disponibles ailleurs sans la permission explicite du détenteur du copyright.

This document was translated from BibT_EX by bibtex2html